focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.60
Bid: 314.50
Ask: 314.60
Change: -2.40 (-0.76%)
Spread: 0.10 (0.032%)
Open: 314.30
High: 315.10
Low: 313.40
Prev. Close: 317.00
NWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adam & Company Private Banking Business

17 Mar 2022 14:09

RNS Number : 1716F
NatWest Group plc
17 March 2022
 

NatWest Group plc

17 March 2022

 

Introduction

Following a detailed review on how its current Adam & Company clients can be best served, NatWest Group plc ("NatWest Group") intends that Coutts & Company will become its principal private bank offering. In order to implement this, it is intended to transfer the private banking (including execution-only dealing services and custody account services) and lending business carried on under the "Adam & Company" brand and trading name by The Royal Bank of Scotland plc ("RBS plc"), a public limited company incorporated in Scotland, to Coutts & Company ("Coutts"), a private unlimited company incorporated in England and Wales.

  

The Scheme

RBS plc and Coutts intend to effect this transfer by using a business banking transfer scheme under Part VII of the Financial Services and Markets Act 2000 ("FSMA").

 

Accordingly, on 17 March 2022 a Petition was presented to the Court of Session in Edinburgh (the "Court") by RBS plc and Coutts for an order under Part VII of the Financial Services and Markets Act 2000 sanctioning a banking business transfer scheme (the "Scheme") for the transfer of the private banking (including execution-only dealing services and custody account services) and lending business carried on by RBS plc under the "Adam & Company" brand and trading name from RBS plc to Coutts.

 

A hearing for the approval of the Scheme is expected to be held on 31 May 2022. If the Scheme is approved at that hearing, the Scheme is expected to take effect on 2 July 2022 or any later date which RBS plc and Coutts may agree, provided that it is no later than 11:59pm (GMT) on 2 October 2022. Implementation of the Scheme is subject, amongst other matters, to Court and regulatory approvals. Unless the context requires otherwise, capitalised terms used in this announcement are defined in the Scheme.

 

Further information on the Scheme

Copies of the Petition, the full terms of the Scheme and a summary of its principal terms are available free of charge at www.adambank.com/transfer or from 36 St Andrew Square, Edinburgh EH2 2YB and will remain available until the date of the Court hearing to consider sanctioning the Scheme.

 

For further information contact:

 

NatWest Group Investor Relations

Alexander HolcroftHead of Investor Relations+44 20 7672 1758

 

NatWest Group Media Relations

+44(0)131 523 4205

 

Making your views known

Any person claiming an interest may lodge formal written objections (known as "Answers") to the petition on or before 11 April 2022. Answers should be lodged at the Court of Session, Petition Department, Parliament House, Edinburgh EH1 1RQ, Scotland. If any person wishes to lodge Answers, they should seek independent legal advice. Answers are a formal Court document which must comply with the rules of the Court and are normally prepared by Scottish legal counsel. In addition, Answers must be accompanied by a fee to the Court.

 

Any person (including an employee of RBS plc or Coutts) who alleges that he or she would be adversely affected by the carrying out of the Scheme has a statutory right to be heard at the Court hearing to consider sanctioning the Scheme. The Court may also consider informal written objections to the Scheme. It would be helpful if anyone who wishes to exercise the statutory right to be heard, or to make informal written objections, could inform RBS plc, by post or by hand, on or before 11 April 2022 at 36 St Andrew Square, Edinburgh EH2 2YB. RBS will advise the Court accordingly and will pass on to the Court any written objections that it has received. No fee is payable for this.

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, such as statements that include, without limitation, the words 'expect', 'should', 'intend', 'could', 'may', 'will' and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as the future economic results, business plans and strategies of NatWest Group plc ("NatWest Group"). Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, the impact of the Covid-19 pandemic, future growth initiatives (including acquisitions, joint ventures and strategic partnerships), the outcome of legal, regulatory and governmental actions and investigations, the level and extent of future impairments and write-downs (including with respect to goodwill), legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations, general economic and political conditions and the impact of climate-related risks and the transitioning to a net zero economy. These and other factors, risks and uncertainties that may impact any forward-looking statement or NatWest Group plc's actual results are discussed in NatWest Group plc's UK 2021 Annual Report and Accounts (ARA) and NatWest Group plc's filings with the US Securities and Exchange Commission, including, but not limited to, NatWest Group plc's most recent Annual Report on Form 20-F and Reports on Form 6-K. The forward-looking statements contained in this document speak only as of the date of this document and NatWest Group plc does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except to the extent legally required. 

 

Legal Entity Identifier

NatWest Group plc

2138005O9XJIJN4JPN90

The Royal Bank of Scotland plc

549300WHU4EIHRP28H10

Coutts & Company

549300OLXJ4Y010LOT3

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBSGDXRGBDGDR
Date   Source Headline
20th May 20245:02 pmRNSTransaction in Own Shares
17th May 20245:54 pmRNSTransaction in Own Shares
16th May 20245:33 pmRNSTransaction in Own Shares
15th May 20245:09 pmRNSTransaction in Own Shares
14th May 20245:12 pmRNSTransaction in Own Shares
14th May 20247:00 amRNSQ1 2024 Pillar 3
13th May 20245:54 pmRNSTransaction in Own Shares
13th May 202410:30 amRNSHolding(s) in Company - HMT shareholding
10th May 20245:09 pmRNSTransaction in Own Shares
9th May 20245:09 pmRNSTransaction in Own Shares
9th May 20242:00 pmRNSDirector/PDMR Shareholding
8th May 20245:37 pmRNSTransaction in Own Shares
8th May 202411:57 amRNSNatWest Group plc Filing of Registration Statement
3rd May 20245:24 pmRNSTransaction in Own Shares
2nd May 20245:55 pmRNSTransaction in Own Shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 20242:00 pmRNSDirector/PDMR Shareholding
30th Apr 20246:02 pmRNSTransaction in Own Shares
30th Apr 20244:27 pmRNSTotal Voting Rights
29th Apr 20245:36 pmRNSTransaction in Own Shares
26th Apr 20245:54 pmRNSPublication of Supplementary Prospectus
26th Apr 202410:30 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSNWG plc Q1 2024 Interim Management Statement
25th Apr 20245:15 pmRNSTransaction in Own Shares
24th Apr 20245:16 pmRNSTransaction in Own Shares
23rd Apr 20245:22 pmRNSTransaction in Own Shares
23rd Apr 20242:22 pmRNSResult of AGM
23rd Apr 20242:02 pmRNSDividend Declaration
23rd Apr 202411:01 amRNSAGM Statement
19th Apr 20245:27 pmRNSTransaction in Own Shares
18th Apr 20245:54 pmRNSTransaction in Own Shares
17th Apr 20245:40 pmRNSTransaction in Own Shares
15th Apr 20245:15 pmRNSTransaction in Own Shares
12th Apr 20245:12 pmRNSTransaction in Own Shares
11th Apr 20245:10 pmRNSTransaction in Own Shares
11th Apr 202411:43 amRNSBlock Listing Six Monthly Return
10th Apr 20245:15 pmRNSTransaction in Own Shares
9th Apr 20245:20 pmRNSTransaction in Own Shares
8th Apr 20245:35 pmRNSTransaction in Own Shares
5th Apr 202410:32 amRNSHolding(s) in Company - HMT shareholding
4th Apr 20245:39 pmRNSTransaction in Own Shares
4th Apr 20248:00 amRNSDirector Declaration
3rd Apr 20245:13 pmRNSTransaction in Own Shares
3rd Apr 20242:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20246:04 pmRNSTransaction in Own Shares
28th Mar 20245:17 pmRNSTransaction in Own Shares
28th Mar 20241:55 pmRNSTotal Voting Rights
27th Mar 20245:31 pmRNSTransaction in Own Shares
27th Mar 20244:21 pmRNSHolding(s) in Company
25th Mar 20242:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.